Emergent BioSolutions (EBS) Sales of Property, Plant and Equipment (2012 - 2025)

Emergent BioSolutions (EBS) Sales of Property, Plant and Equipment (2012 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Sales of Property, Plant and Equipment (Qtr)
1	Haleon	89.28 Bn	87.42 Bn	-	-
2	Teva Pharmaceutical Industries	35.97 Bn	32.23 Bn	1.97 Bn	-
3	Zoetis	32.42 Bn	30.48 Bn	1.62 Bn	10.00 Mn
4	Takeda Pharmaceutical	27.48 Bn	23.42 Bn	4.39 Bn	344,333.70
5	United Therapeutics	22.89 Bn	20.73 Bn	648.10 Mn	-
6	RedHill Biopharma	22.11 Bn	22.11 Bn	-	-
7	Viatris	20.44 Bn	18.64 Bn	1.16 Bn	1.60 Mn
8	Neurocrine Biosciences	17.76 Bn	16.44 Bn	800.70 Mn	-
9	Elanco Animal Health	12.62 Bn	12.19 Bn	785.00 Mn	-
10	Emergent BioSolutions	383.54 Mn	222.04 Mn	84.10 Mn	-

Download Data